Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
If your child has been diagnosed with leiomyosarcoma, you’ll have concerns and questions about her health, treatment, recovery and other issues. It may comfort you to know that leiomyosarcoma is a very rare, but very treatable cancer, and that Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is a world leader in treating children with cancer. We specialize in innovative, family-centered care that supports your child and family every step of the way.
Leiomyosarcomais a very rare, but very treatable cancer. It’s a type of soft tissue sarcoma (cancer) that grows in muscle tissue in muscles, including muscles in the skin and organs. In children, it usually grows in the gastrointestinal tract. Since it is in the soft tissue areas, it can be difficult to detect because they are covered by other structures such as skeletal muscle.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches leiomyosarcoma
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center provides compassionate, comprehensive medical and surgical care for children and adolescents with benign or malignant soft tissue tumors.
Our multidisciplinary approach to care ensures in-depth discussion of each case and personalized treatment plans for every patient. We integrate expertise from the following specialists:
In addition to a multidisciplinary approach, we are starting a personalized medicine approach to make sure we treat each leiomyosarcoma case separately, as each person is unique, down to the molecular level. We develop a treatment plan specifically designed for your child.
Leiomyosarcoma: Reviewed by Carlos Rodriguez-Galindo, MD © Boston Children’s Hospital; posted in 2012
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”